34 results on '"Ledwaba, Johanna"'
Search Results
2. Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000–2016: A Pooled Sequence Analysis
3. Resistance is common in paediatric patients failing ART in South Africa
4. HIV diagnostic challenges in breast-fed infants of mothers on antiretroviral therapy
5. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4–8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011–12 and 2012–13
6. Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch
7. Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa
8. Establishing help-seeking pathways bereaved through perinatal death in Dr George Mukhari Hospital, Gauteng Province
9. Persistent Minority K103N Mutations among Women Exposed to Single-Dose Nevirapine and Virologic Response to Nonnudeoside Reverse-Transcriptase Inhibitor-Based Therapy
10. Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis
11. HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey
12. Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping
13. Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa
14. Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance
15. Low Frequency of Protease Inhibitor Resistance Mutations and Insertions in HIV-1 Subtype C Protease Inhibitor-Naïve Sequences
16. A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria
17. Provincial and National Prevalence Estimates of Transmitted HIV-1 drug Resistance in South Africa Measured using two WHO-recommended Methods
18. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study
19. The use of dried blood spot specimens for HIV-1 drug resistance genotyping in young children initiating antiretroviral therapy
20. Rapid Detection of Common HIV-1 Drug Resistance Mutations by Use of High-Resolution Melting Analysis and Unlabeled Probes
21. Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa
22. Provincial and National Prevalence Estimates of Transmitted HIV-1 drug Resistance in South Africa Measured using two WHO-recommended Methods
23. Population-Based Surveillance of HIV Drug Resistance Emerging on Treatment and Associated Factors at Sentinel Antiretroviral Therapy Sites in Namibia
24. Clinical and virological response to antiretroviral drugs among HIV patients on first-line treatment in Dar-es-Salaam, Tanzania
25. Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch
26. Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites.
27. Rapid Detection of Common HIV-1 Drug Resistance Mutations by Use of High-Resolution Melting Analysis and Unlabeled Probes
28. Genotypic Resistance at Viral Rebound Among Patients Who Received Lopinavir/Ritonavir-Based or Efavirenz-Based First Antiretroviral Therapy in South Africa
29. Drug Resistance Patterns and Virus Re-Suppression among HIV-1 Subtype C Infected Patients Receiving Non-Nucleoside Reverse Transcriptase Inhibitors in South Africa
30. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004
31. Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006
32. Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.
33. Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa.
34. Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.